Governance


The governance consists of the following :

  • The coordinating institution (Université de Montpellier)
  • A steering committee
  • A scientific committee
  • An executive team

 

It operates at two levels, Strategic and Scientific/Operational:

 

Strategic
Scientific and operational

The Steering Committee’s purpose is to define the strategic orientations and the objectives, and to supervise the infrastructure’s activities.


Composition:
•    Christian Jorgensen, coordinator, UM
•    Jacques Mercier,  UM director
•    Louis Casteilla, STROMALab
•    Olivier Detante, GIN, CHU de Grenoble
•    Hélène Rouard, EFS
•    Anaïck Moisan, EFS
•    Philipe Saas, EFS
•    Christophe Martinaud, CTSA

 

 

The Scientific Advisory Board  consists of international experts in the fields of regulatory issues in cell therapy, mesenchymal stem cell, and security and QC in GMP production.


Composition:
•    Giovanni Migliaccio (Scientific Director EATRIS)
•    Pierre Charbord (Emeritus Director Inserm U972)
•    Hubert Schrenzenmeier (Director IKT)

 

 

 

 

 

 

 

The Scientific Committee issues practical recommendations to the Steering committee on the scientific orientations. It suggests novel research strategies and evaluates external projects.


Composition:
•    Christian Jorgensen, coordinator, UM
•    Danièle Noël, U1183
•    Louis Casteilla, STROMALab
•    Olivier Detante, GIN, CHU de Grenoble
•    Hélène Rouard, EFS
•    Karin Tarte, EFS
•    Christophe Martinaud, CTSA

 

 

The Executive team. Its purpose is to coordinate ECELLFRANCE and to drive the changes and implementations decided by the steering committee.

 

Composition:
•    Christian Jorgensen, coordinator, UM
•    Gautier Robin, project manager, UM

•    Christophe Martinaud, CTSA

•    Anaïck Moisan, EFS

•    Louis Casteilla, STROMALab

•    Pascale Plence, UM

•    Sandrine Fleury, EFS

•    Hélène Rouard, EFS